FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083491998> ?p ?o ?g. }

• W2083491998 endingPage "278" @default.
• W2083491998 startingPage "270" @default.
• W2083491998 abstract "Indoleamine 2,3-dioxygenase (IDO), a catabolizing enzyme of tryptophan, is a novel immunosuppressive agent blocking T-cell activation in neoplastic cells, including acute myeloid leukemia (AML) cells. IDO inhibitors as 1-methyl tryptophan (1MT) can abrogate IDO enzymatic activity and may result in an effective immune response. Mononuclear cells (MNCs) were separated from peripheral blood of 25 AML patients and 25 normal adults. IDO expression was detected by RT-PCR and its enzymatic activity by a colorimetric method. MNCs were cultured and the effects of Adriamycin, 1MT and a mixture of both on blast and lymphocyte cell counts after 24 and 72 h were detected. IDO mRNA and activity were detected in 52% of patients and absent in normal subjects. There was a significant correlation between IDO mRNA expression and its enzymatic activity in AML. IDO activity was correlated positively with patient’s ages and negatively with hemoglobin levels. There was a significant inhibition of blast cells proliferation with Adriamycin and more inhibition when combined with 1MT. The inhibition was more after 72 h more than 24 h of culture. However, using 1MT alone showed no significant inhibitory effect on blast cells, with a significant increase in lymphocyte counts. Our study confirms the role of indoleamine 2,3-dioxygenase in tumor-induced immune tolerance and points to the possible benefit of 1-methyl tryptophan as immunotherapeutic enhancing the anticancer effects of traditional chemotherapeutics." @default.
• W2083491998 created "2016-06-24" @default.
• W2083491998 creator A5032177022 @default.
• W2083491998 creator A5043996505 @default.
• W2083491998 creator A5050181519 @default.
• W2083491998 creator A5050260171 @default.
• W2083491998 creator A5072011499 @default.
• W2083491998 creator A5079210432 @default.
• W2083491998 creator A5084549580 @default.
• W2083491998 creator A5086215571 @default.
• W2083491998 date "2010-03-19" @default.
• W2083491998 modified "2023-09-27" @default.
• W2083491998 title "Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells" @default.
• W2083491998 cites W1915573821 @default.
• W2083491998 cites W1967404929 @default.
• W2083491998 cites W1970319521 @default.
• W2083491998 cites W1973251492 @default.
• W2083491998 cites W1984584304 @default.
• W2083491998 cites W1987647023 @default.
• W2083491998 cites W1999228398 @default.
• W2083491998 cites W2008623993 @default.
• W2083491998 cites W2014590681 @default.
• W2083491998 cites W2030923896 @default.
• W2083491998 cites W2031585195 @default.
• W2083491998 cites W2038475311 @default.
• W2083491998 cites W2070311659 @default.
• W2083491998 cites W2081100902 @default.
• W2083491998 cites W2090410108 @default.
• W2083491998 cites W2097191776 @default.
• W2083491998 cites W2097283739 @default.
• W2083491998 cites W2110228704 @default.
• W2083491998 cites W2115230511 @default.
• W2083491998 cites W2125302207 @default.
• W2083491998 cites W2127903252 @default.
• W2083491998 cites W2146914242 @default.
• W2083491998 cites W25973455 @default.
• W2083491998 cites W4234147211 @default.
• W2083491998 cites W4241827523 @default.
• W2083491998 cites W4253434423 @default.
• W2083491998 cites W4293247451 @default.
• W2083491998 doi "https://doi.org/10.1007/s12032-010-9459-6" @default.
• W2083491998 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20300979" @default.
• W2083491998 hasPublicationYear "2010" @default.
• W2083491998 type Work @default.
• W2083491998 sameAs 2083491998 @default.
• W2083491998 citedByCount "21" @default.
• W2083491998 countsByYear W20834919982013 @default.
• W2083491998 countsByYear W20834919982015 @default.
• W2083491998 countsByYear W20834919982016 @default.
• W2083491998 countsByYear W20834919982018 @default.
• W2083491998 countsByYear W20834919982019 @default.
• W2083491998 countsByYear W20834919982020 @default.
• W2083491998 countsByYear W20834919982021 @default.
• W2083491998 countsByYear W20834919982022 @default.
• W2083491998 countsByYear W20834919982023 @default.
• W2083491998 crossrefType "journal-article" @default.
• W2083491998 hasAuthorship W2083491998A5032177022 @default.
• W2083491998 hasAuthorship W2083491998A5043996505 @default.
• W2083491998 hasAuthorship W2083491998A5050181519 @default.
• W2083491998 hasAuthorship W2083491998A5050260171 @default.
• W2083491998 hasAuthorship W2083491998A5072011499 @default.
• W2083491998 hasAuthorship W2083491998A5079210432 @default.
• W2083491998 hasAuthorship W2083491998A5084549580 @default.
• W2083491998 hasAuthorship W2083491998A5086215571 @default.
• W2083491998 hasBestOaLocation W20834919981 @default.
• W2083491998 hasConcept C137061746 @default.
• W2083491998 hasConcept C185592680 @default.
• W2083491998 hasConcept C202751555 @default.
• W2083491998 hasConcept C203014093 @default.
• W2083491998 hasConcept C2776706248 @default.
• W2083491998 hasConcept C2777761686 @default.
• W2083491998 hasConcept C2778461978 @default.
• W2083491998 hasConcept C2778729363 @default.
• W2083491998 hasConcept C2779282312 @default.
• W2083491998 hasConcept C502942594 @default.
• W2083491998 hasConcept C515207424 @default.
• W2083491998 hasConcept C55493867 @default.
• W2083491998 hasConcept C83478079 @default.
• W2083491998 hasConcept C86803240 @default.
• W2083491998 hasConcept C8891405 @default.
• W2083491998 hasConceptScore W2083491998C137061746 @default.
• W2083491998 hasConceptScore W2083491998C185592680 @default.
• W2083491998 hasConceptScore W2083491998C202751555 @default.
• W2083491998 hasConceptScore W2083491998C203014093 @default.
• W2083491998 hasConceptScore W2083491998C2776706248 @default.
• W2083491998 hasConceptScore W2083491998C2777761686 @default.
• W2083491998 hasConceptScore W2083491998C2778461978 @default.
• W2083491998 hasConceptScore W2083491998C2778729363 @default.
• W2083491998 hasConceptScore W2083491998C2779282312 @default.
• W2083491998 hasConceptScore W2083491998C502942594 @default.
• W2083491998 hasConceptScore W2083491998C515207424 @default.
• W2083491998 hasConceptScore W2083491998C55493867 @default.
• W2083491998 hasConceptScore W2083491998C83478079 @default.
• W2083491998 hasConceptScore W2083491998C86803240 @default.
• W2083491998 hasConceptScore W2083491998C8891405 @default.
• W2083491998 hasIssue "1" @default.
• W2083491998 hasLocation W20834919981 @default.
• W2083491998 hasLocation W20834919982 @default.

• next